/
DNPUF
$9.41+$0.54 (+6.04%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$6.34 – $19.20
24% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-2.69
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $459.27B | $482.73B | $515.95B | $560.03B | $555.54B | $314.56B | $398.83B | $456.15B |
| Cost of revenue | $113.55B | $129.67B | $137.77B | $157.13B | $178.92B | $126.58B | $153.44B | $197.64B |
| Gross profit | $345.71B | $353.06B | $378.18B | $402.91B | $376.63B | $187.98B | $245.40B | $258.51B |
| Gross margin | 75.3% | 73.1% | 73.3% | 71.9% | 67.8% | 59.8% | 61.5% | 56.7% |
| R&D | $102.36B | $115.11B | $132.68B | $94.90B | $131.86B | $112.64B | $49.90B | $44.27B |
| Operating income | $57.88B | $83.24B | $71.22B | $60.23B | −$76.98B | −$354.86B | $14.93B | $50.66B |
| EBITDA | $79.23B | $104.17B | $76.97B | $98.31B | −$3.50B | −$317.37B | $38.59B | $71.57B |
| Net income | $48.63B | $40.75B | $56.22B | $56.41B | −$74.51B | −$314.97B | $23.63B | $107.54B |
| Net margin | 10.6% | 8.4% | 10.9% | 10.1% | -13.4% | -100.1% | 5.9% | 23.6% |
| EPS (diluted) | 122.39 | 102.58 | 141.50 | 141.99 | -187.55 | -792.79 | 59.49 | 270.03 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $543.3B | $208.67 | $200.22–$220.28 | 1 |
| 2028 | $593.8B | $204.07 | $195.81–$215.42 | 1 |
| 2029 | $607.2B | $162.86 | $156.27–$171.92 | 1 |
| 2030 | $716.1B | $281.42 | $270.03–$297.08 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
DAI NIPPON PHARM ORD
DAI NIPPON PHARM ORD
Held by traders on TradeandTell
No one on the platform currently holds DNPUF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in DNPUF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded DNPUF yet.